Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis

Laurent Bonnac; Guang Yao Gao; Liqiang Chen; Krzysztof Felczak; Eric M. Bennett; Hua Xu; Tae Soo Kim; Nina Liu; Hye Won Oh; Peter J. Tonge; Krzysztof W. Pankiewicz

doi:10.1016/j.bmcl.2007.05.084

Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis

Laurent Bonnac, Guang Yao Gao, Liqiang Chen, Krzysztof Felczak, Eric M. Bennett, Hua Xu, Tae Soo Kim, Nina Liu, Hye Won Oh, Peter J. Tonge, Krzysztof W. Pankiewicz

Center for Drug Design

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

The chemical synthesis of 4-phenoxybenzamide adenine dinucleotide (3), a NAD analogue which mimics isoniazid-NAD adduct and inhibits Mycobacterium tuberculosis NAD-dependent enoyl-ACP reductase (InhA), is reported. The 4-phenoxy benzamide riboside (1) has been prepared as a key intermediate, converted into its 5′-mononucleotide (2), and coupled with AMP imidazolide to give the desired NAD analogue 3. It inhibits InhA with IC₅₀ = 27 μM.

Original language	English (US)
Pages (from-to)	4588-4591
Number of pages	4
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	17
Issue number	16
DOIs	https://doi.org/10.1016/j.bmcl.2007.05.084
State	Published - Aug 15 2007

Bibliographical note

Funding Information:
These studies were funded by the Center for Drug Design, University of Minnesota. We thank the Minnesota Supercomputing Institute for computer time.

Keywords

Enoyl-ACP reductase (InhA)
Fragment-based drug discovery
Isoniazid
M. tuberculosis
NAD analogues

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.bmcl.2007.05.084

OpenUrl availability

Full text

Cite this

Bonnac, L., Gao, G. Y., Chen, L., Felczak, K., Bennett, E. M., Xu, H., Kim, T. S., Liu, N., Oh, H. W., Tonge, P. J., & Pankiewicz, K. W. (2007). Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis. Bioorganic and Medicinal Chemistry Letters, 17(16), 4588-4591. https://doi.org/10.1016/j.bmcl.2007.05.084

Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis. / Bonnac, Laurent; Gao, Guang Yao; Chen, Liqiang et al.
In: Bioorganic and Medicinal Chemistry Letters, Vol. 17, No. 16, 15.08.2007, p. 4588-4591.

Research output: Contribution to journal › Article › peer-review

Bonnac, L, Gao, GY, Chen, L, Felczak, K, Bennett, EM, Xu, H, Kim, TS, Liu, N, Oh, HW, Tonge, PJ & Pankiewicz, KW 2007, 'Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis', Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 16, pp. 4588-4591. https://doi.org/10.1016/j.bmcl.2007.05.084

@article{415a5ae9e5254949bd7477a912d4f9bb,

title = "Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis",

abstract = "The chemical synthesis of 4-phenoxybenzamide adenine dinucleotide (3), a NAD analogue which mimics isoniazid-NAD adduct and inhibits Mycobacterium tuberculosis NAD-dependent enoyl-ACP reductase (InhA), is reported. The 4-phenoxy benzamide riboside (1) has been prepared as a key intermediate, converted into its 5′-mononucleotide (2), and coupled with AMP imidazolide to give the desired NAD analogue 3. It inhibits InhA with IC50 = 27 μM.",

keywords = "Enoyl-ACP reductase (InhA), Fragment-based drug discovery, Isoniazid, M. tuberculosis, NAD analogues",

author = "Laurent Bonnac and Gao, {Guang Yao} and Liqiang Chen and Krzysztof Felczak and Bennett, {Eric M.} and Hua Xu and Kim, {Tae Soo} and Nina Liu and Oh, {Hye Won} and Tonge, {Peter J.} and Pankiewicz, {Krzysztof W.}",

note = "Funding Information: These studies were funded by the Center for Drug Design, University of Minnesota. We thank the Minnesota Supercomputing Institute for computer time. ",

year = "2007",

month = aug,

day = "15",

doi = "10.1016/j.bmcl.2007.05.084",

language = "English (US)",

volume = "17",

pages = "4588--4591",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "16",

}

TY - JOUR

T1 - Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis

AU - Bonnac, Laurent

AU - Gao, Guang Yao

AU - Chen, Liqiang

AU - Felczak, Krzysztof

AU - Bennett, Eric M.

AU - Xu, Hua

AU - Kim, Tae Soo

AU - Liu, Nina

AU - Oh, Hye Won

AU - Tonge, Peter J.

AU - Pankiewicz, Krzysztof W.

N1 - Funding Information: These studies were funded by the Center for Drug Design, University of Minnesota. We thank the Minnesota Supercomputing Institute for computer time.

PY - 2007/8/15

Y1 - 2007/8/15

N2 - The chemical synthesis of 4-phenoxybenzamide adenine dinucleotide (3), a NAD analogue which mimics isoniazid-NAD adduct and inhibits Mycobacterium tuberculosis NAD-dependent enoyl-ACP reductase (InhA), is reported. The 4-phenoxy benzamide riboside (1) has been prepared as a key intermediate, converted into its 5′-mononucleotide (2), and coupled with AMP imidazolide to give the desired NAD analogue 3. It inhibits InhA with IC50 = 27 μM.

AB - The chemical synthesis of 4-phenoxybenzamide adenine dinucleotide (3), a NAD analogue which mimics isoniazid-NAD adduct and inhibits Mycobacterium tuberculosis NAD-dependent enoyl-ACP reductase (InhA), is reported. The 4-phenoxy benzamide riboside (1) has been prepared as a key intermediate, converted into its 5′-mononucleotide (2), and coupled with AMP imidazolide to give the desired NAD analogue 3. It inhibits InhA with IC50 = 27 μM.

KW - Enoyl-ACP reductase (InhA)

KW - Fragment-based drug discovery

KW - Isoniazid

KW - M. tuberculosis

KW - NAD analogues

UR - http://www.scopus.com/inward/record.url?scp=34447336119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447336119&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2007.05.084

DO - 10.1016/j.bmcl.2007.05.084

M3 - Article

C2 - 17560106

AN - SCOPUS:34447336119

SN - 0960-894X

VL - 17

SP - 4588

EP - 4591

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 16

ER -

Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this